The present invention relates to a compound of formula (I) or an acceptable salt thereof (I)
JPEG2025535882000141.jpg29170 [wherein W, X, Y and Z each independently represent =CH- or -N=, provided that a maximum of two of W, X, Y and Z both represent -N= groups; R1 represents a linear or cyclic
nitrogen-containing (C4-C8)
alkyl group, said group being a non-aromatic (C4-C8)
alkyl group which may be linear or cyclic and contains 4 to 8 carbon atoms, with at least one
nitrogen atom interrupting the
alkyl chain, said group being optionally interrupted by one or two
oxygen atoms and optionally substituted by a (C1-C4) alkyl group or a (C3-C6) cycloalkyl group; R2 is a
hydrogen atom, a
halogen atom, R3 represents a
hydrogen atom, a
halogen atom, a (C1-C4) alkyl group, a (C1-C4)
alkoxy group, a (C1-C4) fluoroalkyl group, a -CO-(C1-C4) alkyl group, a -CONH2 group, a SO2-NH2 group, or a cyano group; R3 represents a
hydrogen atom, a
halogen atom, a (C1-C4) alkyl group, a (C1-C4)
alkoxy group, a (C1-C4) fluoroalkyl group, a cyano group, a (C1-C4) alkylsulfonyl group, or a SO2-NH2 group; and R4, R5, and R6 independently represent a
hydrogen atom, a halogen atom, a -COOH group, a -COO(C1-C4) alkyl group, a (C1-C4) fluoroalkyl group, a (C1-C4) alkylsulfonyl group, or a (C1-C4)
alkoxy group. The present invention further relates to pharmaceutical compositions containing the same, and to their use in the prevention and / or treatment of pain.